- China’s healthcare system still lags in recovery from the Zero-COVID era, with outpatient visits significantly below pre-pandemic levels.
- Urban centers have seen partial recovery, but rural health facilities operate at a fraction of their pre-2020 capacity.
- The urban-rural divide in healthcare access has grown due to prolonged restrictions, economic hardship, and patient distrust during the pandemic.
- Outpatient visits dropped 37% nationally during the peak Zero-COVID period and have only recovered to 84% of pre-pandemic levels.
- Rural areas face a steeper shortfall, with visits 22% below baseline and some provinces reporting utilization rates as low as 78% of 2019 levels.
China’s health care system has not fully rebounded from the disruptions of the Zero-COVID era, with outpatient visits remaining significantly below pre-pandemic levels—particularly in rural regions. A comprehensive analysis published in PLOS Medicine and led by researchers at Fred Hutch Cancer Center reveals that while urban centers have seen partial recovery, rural health facilities continue to operate at a fraction of their pre-2020 capacity. The findings underscore a growing urban-rural divide in health care access, driven by prolonged restrictions, economic hardship, and erosion of patient trust in the health system during the pandemic.
Outpatient Visits Show Persistent Decline
The PLOS Medicine study analyzed anonymized electronic health records from over 1,200 primary care clinics across 28 Chinese provinces between January 2018 and December 2023. It found that national outpatient visit volumes dropped by 37% during the peak Zero-COVID period (2020–2022) and have only recovered to 84% of pre-pandemic levels by mid-2023. In rural areas, the shortfall is far steeper: visits remain 22% below baseline, with some provinces in central and western China reporting utilization rates as low as 78% of 2019 levels. The researchers adjusted for population changes and seasonal illness trends, confirming that the deficit is not due to improved public health but rather suppressed demand. Chronic disease management was especially affected—diabetes consultations fell by 18%, and hypertension follow-ups by 15% in rural clinics, raising concerns about long-term complications.
Key Players: Government, Providers, and Patients
The Chinese government, provincial health bureaus, primary care providers, and patients all play critical roles in the ongoing recovery. National health authorities have launched campaigns to rebuild confidence in outpatient services, including subsidized screenings and telemedicine expansion. However, implementation varies widely: urban districts like Shanghai’s Xuhui and Beijing’s Haidian have restored 95% of pre-pandemic visits through digital health integration and outreach, while rural clinics in Gansu and Guizhou struggle with staffing shortages and limited funding. Local governments in poorer regions face tight budgets, and many primary care physicians report burnout from pandemic-era overwork and reduced patient loads. Meanwhile, patients—especially older adults in rural areas—remain hesitant to seek care, citing fear of infection, transport costs, and a perception that clinics are understaffed or under-resourced.
Trade-Offs Between Public Health and System Resilience
The Zero-COVID strategy, while effective in limiting acute pandemic mortality, imposed significant trade-offs for long-term health system performance. Strict lockdowns, mass testing, and hospital repurposing disrupted routine care and diverted resources from chronic disease management. While these measures saved lives during surges, they also eroded public trust and delayed diagnoses—especially for time-sensitive conditions like cancer. The study notes a 31% decline in early-stage cancer screenings in rural areas during 2021–2022, a lag that could translate into higher mortality in the coming decade. On the other hand, the crisis accelerated digital health investments, with over 60% of urban clinics now offering teleconsultations. Yet without equitable access to technology and broadband, these innovations risk deepening disparities rather than closing them.
Why the Recovery Is Stalling Now
The pace of recovery slowed notably after early 2023, despite the formal end of Zero-COVID policies in December 2022. This stagnation reflects structural challenges rather than transient factors. Economic headwinds, including youth unemployment and declining local government revenues, have reduced household spending on non-emergency care. At the same time, health care providers face a backlog of unmet need and insufficient incentives to scale up services. Unlike countries with rapid V-shaped recoveries—such as South Korea or Germany—China’s decentralized health system lacks coordinated reactivation strategies. Moreover, behavioral changes persist: patients now prefer to self-medicate or delay visits, a shift reinforced by pandemic messaging that discouraged non-essential outings. These factors, combined with ongoing supply-side constraints, explain why utilization has plateaued below pre-crisis norms.
Where We Go From Here
Over the next 6 to 12 months, China’s health care system could follow one of three trajectories. In an optimistic scenario, targeted investments in rural clinics, expanded insurance coverage for preventive care, and public awareness campaigns could close the utilization gap by late 2024. A more likely middle path involves gradual recovery, with urban areas normalizing but rural deficits persisting due to funding and workforce limitations. In a pessimistic scenario, without policy intervention, suppressed demand could lead to a rise in advanced disease presentations, increasing long-term health care costs and mortality. The trajectory will depend on whether national leaders prioritize primary care revitalization in the upcoming Five-Year Plan for Health.
Bottom line — without urgent action to address rural health care access, China risks entrenching a post-pandemic underutilization crisis that could undermine decades of progress in public health.
Source: MedicalXpress